Haemonetics Corp. buy Mizuho
Start price
17.12.25
/
50%
€67.50
Target price
17.12.26
€76.62
Performance (%)
-25.19%
Price
16.02.26
€48.80
Summary
This prediction is currently active. The price of Haemonetics Corp. has decreased since the start of the prediction. Compared to the start price this results in a performance of -25.19%. This prediction currently runs until 17.12.26. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | 0.826% | 0.826% |
| iShares Core DAX® | 1.066% | -0.525% |
| iShares Nasdaq 100 | -0.493% | -4.055% |
| iShares Nikkei 225® | -2.028% | 6.911% |
| iShares S&P 500 | -0.103% | -2.366% |
Comments by Mizuho for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics (NYSE:HAE) had its price target raised by analysts at Mizuho from $75.00 to $90.00. They now have an "outperform" rating on the stock.
Ratings data for HAE provided by MarketBeat